Mode
Text Size
Log in / Sign up

Transcranial Magnetic Stimulation reduces motor overflow in focal dystonia and improves stroke and cerebral palsy outcomesTMS Treatment Shows Potential for Reducing Motor Overflow

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that TMS shows potential to reduce motor overflow in focal dystonia but requires standardized protocols for other conditions.

This systematic review synthesizes evidence regarding the use of transcranial magnetic stimulation (TMS) to manage motor overflow and related symptoms in patients with stroke, cerebral palsy, Parkinson's disease, and focal hand dystonia. The authors highlight that TMS, particularly high-frequency protocols, shows potential for modulating motor overflow specifically in cases of focal dystonia, as evidenced by improved handwriting kinematics.

For Parkinson's disease, the review notes a reduction in interhemispheric inhibition (IHI) following SMA stimulation, though mirror movements remained unchanged. In patients with stroke and cerebral palsy, improvements were consistently reported across secondary outcomes including motor function, spasticity, and cortical excitability. However, the authors note that motor overflow was only directly assessed in two studies involving Parkinson's disease and dystonia.

The review identifies several limitations, including a lack of standardized outcome measures, gaps in allocation reporting, and limited cross-study comparisons. Because evidence for direct effects on motor overflow in stroke and cerebral palsy was not directly evaluated, the findings are considered condition-specific. Clinical application is currently limited by the need for more trials using standardized protocols to confirm efficacy across diverse neurological conditions.

How this fits prior evidence

This systematic review addresses a gap in understanding how transcranial magnetic stimulation (TMS) modulates motor overflow and related symptoms across multiple neurological conditions. While previous coverage noted that sex-specific genetic risk loci and causal proteins exist in Parkinson's disease, this review focuses on the physiological modulation of such conditions via TMS. It also provides evidence for managing symptoms in stroke patients, a population previously discussed in the context of DAPT and aspirin management for minor acute ischemic stroke.

Researchers reviewed how Transcranial Magnetic Stimulation (TMS) affects motor overflow, which is when muscles move involuntarily. The review looked at several conditions, including stroke, cerebral palsy, Parkinson's disease, and focal hand dystonia.

For patients with focal hand dystonia, the study found significant reductions in movement overflow during tasks like handwriting. For those with Parkinson's disease, while mirror movements did not change, there was a reduction in certain physiological markers after specific stimulation. In cases of stroke and cerebral palsy, researchers consistently reported improvements in motor function and spasticity.

It is important to note that the evidence for these results is still preliminary and varies by condition. For example, motor overflow was only directly measured in two studies involving Parkinson's and dystonia. Because many measures were not standardized across different studies, more research is needed to confirm how well this treatment works for everyone.

What this means for you:
TMS shows promise for reducing involuntary movements in specific conditions, but more standardized research is needed.

Common questions

What is motor overflow?

Motor overflow happens when muscles move involuntarily. This study looked at how Transcranial Magnetic Stimulation (TMS) can reduce these movements in people with conditions like focal hand dystonia, where it was shown to improve handwriting kinematics.

How does TMS help patients with stroke or cerebral palsy?

In studies involving stroke and cerebral palsy, researchers consistently reported improvements in motor function, spasticity, and cortical excitability. However, the study did not directly measure motor overflow for these specific conditions.

Is TMS effective for Parkinson's disease?

The results for Parkinson's disease were mixed. While mirror movements remained unchanged, researchers observed a reduction in interhemispheric inhibition after certain stimulations. More research is needed to determine the best protocols.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
Motor overflow, a neuromotor phenomenon characterized by involuntary activation of muscles during voluntary movement, reflects impairments in interhemispheric and intracortical inhibition and is commonly observed in conditions such as stroke, cerebral palsy, dystonia, and Parkinson’s disease. Transcranial Magnetic Stimulation (TMS) is a non-invasive neuromodulatory technique with potential to modulate the cortical excitability underlying overflow-related dysfunctions. This systematic review aimed to evaluate the efficacy of TMS in reducing motor overflow across neurological populations. Seven randomized controlled trials (RCTs) were included, encompassing participants with stroke, cerebral palsy, Parkinson’s disease, and focal hand dystonia. Protocols varied in frequency (1–10 Hz), target area (M1, SMA, PSC, PMC), and design (e.g., crossover, combined protocols with constraint-induced therapy or cerebellar stimulation; Motor overflow was directly assessed in only two studies, one involving Parkinson’s disease and one involving dystonia, thereby limiting cross-study comparisons. Therefore, evidence supporting a direct effect of TMS on motor overflow remains preliminary and condition-specific. In dystonia, high-frequency rTMS (10 Hz) targeting the primary somatosensory cortex led to significant reductions in overflow, demonstrated by handwriting kinematics. In Parkinson’s disease, although physiological modulation (reduced IHI) was observed after SMA stimulation, mirror movements remained unchanged. In stroke and cerebral palsy populations, overflow was not directly evaluated, though improvements in motor function, spasticity, and cortical excitability were consistently reported. Risk of bias was low in most included studies, although gaps in allocation reporting and standardization of outcome measures were noted. This review highlights the potential of TMS, particularly high-frequency protocols, to modulate motor overflow in focal dystonia. However, the lack of targeted assessment in other neurological conditions suggests a critical need for future trials with standardized protocols and specific outcome measures focused on overflow to clarify the therapeutic role of TMS in rehabilitation.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.